Morgan Stanley Maintains Underweight on Doximity, Lowers Price Target to $21
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser maintains an Underweight rating on Doximity (NYSE:DOCS) and lowers the price target from $28 to $21.
August 09, 2023 | 12:46 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley has maintained an Underweight rating on Doximity and lowered the price target from $28 to $21.
The lowered price target by Morgan Stanley indicates a bearish outlook for Doximity. This could potentially lead to a decrease in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100